NextGen's 2010 Revenues Improve 4 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein biomarker and assay development firm NextGen Group announced on Friday that 2010 revenues increased 4 percent to a little more $1.2 million.

That compares to 2009 revenues of slightly less than $1.2 million.

For the year, the UK-based firm's net loss improved 8 percent to $3.3 million, or $.06 per share, from $3.6 million, $.11 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.